The Epinex G1A™ Rapid Diabetes Monitoring Index Test is a new monthly rapid test that uses glycated albumin to measure how much damage has been done to….Full Story

Generex Biotechnology announced today the successful Phase III study data for their buccal oral insulin product, Oral-lyn™. The product’s non-inferiority to injectable meal-time (prandial) insulin appears to be real and repeatable. Update on Oral-lyn

Timing is everything. This week, dLife talks about pets and diabetes and David Kliff, Publisher of Diabetic Investor, has found out that a major meter company is going to take over the market. Click here to read Abbott Finds the Answer and it’s the Cat’s Meow.

If your patients are female, past puberty, and still young enough to be menstruating, then you’ll want to read what Sheri Colberg, Ph.D., FACSM, has to say in this week’s feature; Being Female and Athletic: Special Concerns for Diabetic Women Only.

A virus with symptoms like those of the common cold may be a trigger for diabetes, especially in children, according to two UK studies that suggest doctors may one day be able to vaccinate against the disease.

People with severe psoriasis are at an increased risk of developing serious medical conditions, including cardiovascular disease and diabetes, says a dermatologist from the University of Pennsylvania.

One in three people with Type 2 diabetes are given medication too soon, instead of being urged to eat better and do more exercise, a UK study suggests.

The FDA will take longer to review Alogliptin, an experimental diabetes pill developed by Takeda, delaying a potential blockbuster billion-dollar seller from reaching the market.

Surge in anxiety-linked hormone worsens blood sugar level, researchers suggest and stress may play a key role in the development of Type 2 diabetes in obese black women, U.S. researchers say.

Drugs blocking this communication may offer therapeutic benefits, study finds.